🔎 Trials Near Me

Home › Pancreatic Cancer › Rhode Island › Providence

Pancreatic Cancer clinical trials in Providence, RI

5 studies for Pancreatic Cancer are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

RecruitingPhase 3
  • Brown University Health Cancer Institute - Division of Hematology/Oncology, Providence
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07409272

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

RecruitingPhase 3
  • Rhode Island Hospital, Providence
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

RecruitingPhase 2
  • Brown University Cancer Institute, Providence
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06850623

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Providence
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

RecruitingPhase 1
  • Rhode Island Hospital, Providence
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542

About Pancreatic Cancer

The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.

More about Pancreatic Cancer on MedlinePlus

Pancreatic Cancer trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.